» Articles » PMID: 35794339

Application of ATAC-seq in Tumor-specific T Cell Exhaustion

Overview
Date 2022 Jul 6
PMID 35794339
Authors
Affiliations
Soon will be listed here.
Abstract

Researches show that chronic viral infection and persistent antigen and/or inflammatory signal exposure in cancer causes the functional status of T cells to be altered, mainly by major changes in the epigenetic and metabolic environment, which then leads to T cell exhaustion. The discovery of the immune checkpoint pathway is an important milestone in understanding and reversing T cell exhaustion. Antibodies targeting these pathways have shown superior ability to reverse T cell exhaustion. However, there are still some limitations in immune checkpoint blocking therapy, such as the short-term nature of therapeutic effects and high individual heterogeneity. Assay for transposase-accessible chromatin with sequencing(ATAC-seq) is a method used to analyze the accessibility of whole-genome chromatin. It uses hyperactive Tn5 transposase to assess chromatin accessibility. Recently, a growing number of studies have reported that ATAC-seq can be used to characterize the dynamic changes of epigenetics in the process of T cell exhaustion. It has been determined that immune checkpoint blocking can only temporarily restore the function of exhausted T cells because of an irreversible change in the epigenetics of exhausted T cells. In this study, we review the latest developments, which provide a clearer molecular understanding of T cell exhaustion, reveal potential new therapeutic targets for persistent viral infection and cancer, and provide new insights for designing effective immunotherapy for treating cancer and chronic infection.

Citing Articles

Utilization of Microfluidic Droplet-Based Methods in Diagnosis and Treatment Methods of Hepatocellular Carcinoma: A Review.

Zajanckauskaite A, Lingelbach M, Juozapaite D, Utkus A, Ruksnaityte G, Jonuskiene G Genes (Basel). 2024; 15(10).

PMID: 39457366 PMC: 11508129. DOI: 10.3390/genes15101242.


JunB is required for CD8+ T cell responses to acute infections.

Sarkar S, Taira N, Hsieh T, Chien H, Hirota M, Koizumi S Int Immunol. 2024; 37(4):203-220.

PMID: 39425978 PMC: 11884676. DOI: 10.1093/intimm/dxae063.


A therapeutic HBV vaccine containing a checkpoint modifier enhances CD8+ T cell and antiviral responses.

Hasanpourghadi M, Novikov M, Ambrose R, Chekaoui A, Newman D, Xiang Z JCI Insight. 2024; 9(21).

PMID: 39226106 PMC: 11601613. DOI: 10.1172/jci.insight.181067.


Therapeutic targeting ERRγ suppresses metastasis via extracellular matrix remodeling in small cell lung cancer.

Wang H, Sun H, Huang J, Zhang Z, Cai G, Wang C EMBO Mol Med. 2024; 16(9):2043-2059.

PMID: 39085398 PMC: 11393344. DOI: 10.1038/s44321-024-00108-z.


Construction and validation of prognostic signature for transcription factors regulating T cell exhaustion in hepatocellular carcinoma.

Jin X, Zhou K, Zhang R, Li J, Guo M, Qiao H Medicine (Baltimore). 2024; 103(27):e38713.

PMID: 38968464 PMC: 11224837. DOI: 10.1097/MD.0000000000038713.


References
1.
Lyu Q, Lin A, Cao M, Xu A, Luo P, Zhang J . Alterations in TP53 Are a Potential Biomarker of Bladder Cancer Patients Who Benefit From Immune Checkpoint Inhibition. Cancer Control. 2020; 27(1):1073274820976665. PMC: 8480364. DOI: 10.1177/1073274820976665. View

2.
Garcia-Diaz A, Shin D, Moreno B, Saco J, Escuin-Ordinas H, Rodriguez G . Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression. Cell Rep. 2017; 19(6):1189-1201. PMC: 6420824. DOI: 10.1016/j.celrep.2017.04.031. View

3.
Staron M, Gray S, Marshall H, Parish I, Chen J, Perry C . The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infection. Immunity. 2014; 41(5):802-14. PMC: 4270830. DOI: 10.1016/j.immuni.2014.10.013. View

4.
Hogan P, Chen L, Nardone J, Rao A . Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 2003; 17(18):2205-32. DOI: 10.1101/gad.1102703. View

5.
Bengsch B, Ohtani T, Khan O, Setty M, Manne S, OBrien S . Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells. Immunity. 2018; 48(5):1029-1045.e5. PMC: 6010198. DOI: 10.1016/j.immuni.2018.04.026. View